Paradigm Biocapital Advisors LP → Viridian Therapeutics, Inc. VRDN

Stake: — Shares: — CUSIP: 92790C104 Class: Common Stock, $0.01 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-07-31

DTC 11.31

19,234,874 shares short · +1.6% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $7.91M

Point72 Asset Mgmt

Other 13D/G Filings on Viridian Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-05-13	SCHEDULE 13D/A	Fairmount Funds Management LLC	—	17,201,800	view →
2024-04-01	SC	Fairmount Funds Management LLC	—	—	view →
2021-09-23	SC	Fairmount Funds Management LLC	—	—	view →

Other Filings by Paradigm Biocapital Advisors LP

Filed	Form	Issuer	Stake	Shares
2026-06-24	SCHEDULE 13G	MBX Biosciences, Inc. MBX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →